Nyeste anskaffelser av vaksiner mot difteri og stivkrampe i Norge
2023-08-30Pertussis vaccine for maternal immunisation (Folkehelseinstituttet)
The Norwegian Institute of Public Health is holding an open tender contest with the aim of entering into a contract for the supply of vaccines suitable for vaccination against pertussis during pregnancy (maternal vaccination, vaccination of pregnant women). In practice, this would mean a combination vaccine against diphtheria, tetanus and pertussis, without a polio component.
Vis anskaffelsen »
2023-07-03Hexavalent vaccine - a combination vaccine against diphtheria, tetanus, whooping cough, polio, Hib and hepatitis B (Folkehelseinstituttet)
The Norwegian Institute of Public Health would like to procure diphtheria, tetanus, whooping cough, polio, Haemophilus influenza type B, and hepatitis B combination vaccines (hexavalent vaccine) for babies in the Norwegian child vaccination programme. The procurement is carried out on behalf of the Ministry of Health and Care Services (HOD).
The contest is being held electronically in the CTM KGV and information given in the tender management tool, in the notice, and the tender documentation stipulates …
Vis anskaffelsen »
2021-07-26Vaccine Against Diphtheria, Tetanus, Pertussis and Poliomyelitis for 2nd School Year Students in the Norwegian Child... (Folkehelseinstituttet)
Folkehelseinstituttet (the Norwegian Institute of Public Health) is holding an open tender contest with the aim of entering into a framework agreement for the delivery of a vaccine against diphtheria, tetanus, pertussis and poliomyelitis for children in the 2nd school year. The vaccination is a part of the Norwegian child vaccination programme.
The competition will be implemented as an open tender competition in accordance with the Public Procurement Regulations' Parts 1 and 3. Award will be based on the …
Vis anskaffelsen »
2019-04-16Hexavalent Vaccine — A Combination Vaccine against Diphtheria, Tetanus, Whooping Cough, Polio, Hib and Hepatitis B (Folkehelseinstituttet)
The Norwegian Institute of Public Health shall enter into a contract for the purchase of a combination vaccine for diphtheria, tetanus, whooping cough, polio, Hib and hepatitis B (hexavalent vaccine), for the national vaccine programme. The tender contest is carried out on behalf of the Norwegian Institute of Public Health (HOD). Norway has had a hexavalent vaccine programme since 2016. The current contract expires 31.12.2019 and shall be replaced by a new contract subsequent to the tender …
Vis anskaffelsen » Nevnte leverandører:GlaxoSmithKline AS
2016-06-18A combination vaccine against diphtheria, tetanus, whooping cough, polio, Hib and hepatitis B (The Norwegian Institute of Public Health)
The Norwegian Institute of Public Health shall enter into an agreement regarding the purchase of a combination vaccine for the diseases: diphtheria, whooping cough, tetanus, polio, Hib and hepatitis B (a 6 component vaccine), for the National Vaccine Programme. The 6 component vaccine shall replace the current 5 component vaccine (diphtheria, whooping cough, tetanus, polio and Hib) and partly vaccine against hepatitis B for defined risk groups. The procurement is carried out on behalf of the Norwegian …
Vis anskaffelsen »